多西尔化水化合物与丁甲基联合治疗中风后认知障碍的治疗效果
Yuxin Pang1, Zhibin Han2, Chen Xu3
1Department of Pathology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang, China.
American journal of translational research
|July 15, 2024
概括
将多尼佩西尔化物 (DPZ) 与丁甲基 (BP) 结合使用,可显著改善中风后认知障碍 (PSCI) 患者的认知功能和日常生活活动. 这种组合疗法是有效和安全的,为PSCI提供了有前途的治疗方法.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 脑卒中康复治疗 脑卒中康复治疗
背景情况:
- 脑卒中后认知障碍 (PSCI) 是脑血管事故的常见和使人虚弱的后果.
- 改善PSCI患者认知功能和日常生活活动的有效治疗策略对于康复和生活质量至关重要.
研究的目的:
- 评估将多尼化 (DPZ) 与丁 (BP) 结合用于治疗PSCI的治疗效果和安全性.
- 为了比较DPZ加BP与单独DPZ在改善认知功能,神经缺陷和相关生化标志物的疗效.
主要方法:
- 一项回顾性研究分析了2019年12月至2023年12月期间治疗的125名PSCI患者的数据.
- 患者被分为一个联合组 (DPZ + BP,n=75) 和一个控制组 (单独DPZ,n=50).
- 评估的结果包括治疗有效性,安全性,认知功能 (MoCA,CSS),ADL和血清生物标志物 (NSE,hs-CRP,NO,MDA).
主要成果:
- 组合组 (DPZ + BP) 与DPZ单独组 (P<0.05) 相比,显示出明显更高的治疗效果.
- 在组合组中观察到MoCA和ADL得分的显著改善,以及CSS得分,NSE,hs-CRP,NO和MDA水平的降低 (所有P<0.05).
- 两组之间在不良反应的总发病率上没有发现显著差异 (P>0.05).
结论:
- 多西尔化与丁甲基结合,是PSCI的高效治疗方法.
- 这种组合疗法对认知功能,日常生活活动 (ADL),神经学缺陷和血清生物化学指数产生积极影响.
- 联合治疗为PSCI提供了安全有效的治疗选择,而不会增加不良事件风险.
更多相关视频
07:42Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
2.9K
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.2K
相关概念视频
Alzheimer's Disease: Treatment
177
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
177
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
118
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
118
Parkinson's Disease: Treatment
251
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
251
